Published in Neurol Sci on May 24, 2013
Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet (2007) 10.74
Treatment and outcomes of acute basilar artery occlusion in the Basilar Artery International Cooperation Study (BASICS): a prospective registry study. Lancet Neurol (2009) 3.36
Basilar artery occlusion. Lancet Neurol (2011) 1.72
Glycoprotein IIb-IIIa inhibitors for acute ischaemic stroke. Cochrane Database Syst Rev (2006) 1.46
Combined treatment with intravenous abciximab and intraarterial tPA yields high recanalization rate in patients with acute basilar artery occlusion. J Neuroimaging (2011) 1.43
Collateral circulation and outcome after basilar artery thrombolysis. AJNR Am J Neuroradiol (1998) 1.12
Intravenous glycoprotein IIb/IIIa inhibitor (tirofiban) followed by intra-arterial urokinase and mechanical thrombolysis in stroke. AJNR Am J Neuroradiol (2005) 1.03
Emergent stent placement following intra-arterial thrombolysis for the treatment of acute basilar artery occlusion. J Clin Neurosci (2011) 1.02
Three-month and long-term outcomes and their predictors in acute basilar artery occlusion treated with intra-arterial thrombolysis. Stroke (2011) 0.91
A case of recurrent basilar artery occlusion successfully treated with repeated intravascular procedures. Neurologist (2011) 0.84
Axillary lymph node staging in breast cancer by 2-fluoro-2-deoxy-D-glucose-positron emission tomography: clinical evaluation and alternative management. J Natl Cancer Inst (2001) 2.57
White matter hyperintensities in Parkinson's disease. Clinical correlations. Arch Neurol (1995) 2.30
Psychiatric comorbidity in a population of Parkinson's disease patients. Eur J Neurol (2004) 1.80
Altered maturation of peripheral blood dendritic cells in patients with breast cancer. Br J Cancer (2003) 1.65
IV amantadine improves chorea in Huntington's disease: an acute randomized, controlled study. Neurology (2003) 1.60
Oxidative damage and cytogenetic analysis in leukocytes of Parkinson's disease patients. Neurology (2002) 1.51
Tau forms in CSF as a reliable biomarker for progressive supranuclear palsy. Neurology (2008) 1.50
White matter MRI hyperintensities in a hundred and twenty-nine consecutive migraine patients. Cephalalgia (1994) 1.49
Impact of nodal status on indication for adjuvant treatment in clinically node negative breast cancer. Istituto Nazionale per lo Studio e las Cura dei Tumori. Ann Oncol (2000) 1.46
Vertebral and carotid artery dissection following chiropractic cervical manipulation. Neurosurg Rev (1999) 1.38
Delayed iatrogenic aortic dissection from coronary bypass managed with extraanatomic bypass. J Thorac Cardiovasc Surg (1998) 1.37
REM sleep behaviour disorder in Parkinson's disease: a questionnaire-based study. Neurol Sci (2005) 1.30
A study of five candidate genes in Parkinson's disease and related neurodegenerative disorders. European Study Group on Atypical Parkinsonism. Neurology (1999) 1.25
Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease. Eur J Neurol (2013) 1.24
A short scale for the assessment of motor impairments and disabilities in Parkinson's disease: the SPES/SCOPA. J Neurol Neurosurg Psychiatry (2004) 1.20
Role of electrothrombosis in aneurysm treatment with Guglielmi detachable coils: an in vitro scanning electron microscopic study. AJNR Am J Neuroradiol (2001) 1.15
Psychiatric comorbidity and psychosocial stress in patients with tension-type headache from headache centers in Italy. The Italian Collaborative Group for the Study of Psychopathological Factors in Primary Headaches. Cephalalgia (1999) 1.13
Paroxetine in Parkinson's disease: effects on motor and depressive symptoms. Neurology (2000) 1.11
The diverse phenotype and genotype of pantothenate kinase-associated neurodegeneration. Neurology (2005) 1.07
Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease. Mov Disord (2001) 1.05
Intravenous amantadine improves levadopa-induced dyskinesias: an acute double-blind placebo-controlled study. Mov Disord (2001) 1.03
Bilateral medial frontal infarction in a case of azygous anterior cerebral artery stenosis. Ital J Neurol Sci (1998) 1.02
Spinocerebellar ataxia type 2 in southern Italy: a clinical and molecular study of 30 families. J Neurol (1999) 1.00
MRI and MR angiography of vertebral artery dissection. Neuroradiology (1997) 0.99
Assessment of midbrain atrophy in patients with progressive supranuclear palsy with routine magnetic resonance imaging. Acta Neurol Scand (2007) 0.98
Epidural spinal cavernous hemangioma. Spine (Phila Pa 1976) (1998) 0.98
Cytogenetic analysis oxidative damage in lymphocytes of Parkinson's disease patients. Neurol Sci (2001) 0.97
Use of a high-risk human papillomavirus DNA test as the primary test in a cervical cancer screening programme: a population-based cohort study. BJOG (2013) 0.97
Preferential occurrence of chromosome 21 malsegregation in peripheral blood lymphocytes of Alzheimer disease patients. Cytogenet Cell Genet (1999) 0.97
SSRIs do not worsen Parkinson's disease: evidence from an open-label, prospective study. Clin Neuropharmacol (2001) 0.96
Epidemiology of multiple system atrophy. ESGAP Consortium. European Study Group on Atypical Parkinsonisms. Neurol Sci (2001) 0.96
The relationship between cerebral vascular disease and parkinsonism: The VADO study. Parkinsonism Relat Disord (2012) 0.96
Weight cycling in treatment-seeking obese persons: data from the QUOVADIS study. Int J Obes Relat Metab Disord (2004) 0.94
The clinical significance of gastric epithelial dysplasia. Endoscopy (1986) 0.94
Clinical diagnosis of multiple system atrophy: level of agreement between Quinn's criteria and the consensus conference guidelines. Acta Neurol Scand (2001) 0.92
Acute and chronic effects of clozapine in essential tremor. Mov Disord (1999) 0.92
A case of sarcoidosis presenting as a non-specific intramedullary lesion. Eur J Neurol (2007) 0.92
Improvement of motor function in early Parkinson disease by safinamide. Neurology (2004) 0.91
Clinical outcome and magnetic resonance imaging of carbon monoxide intoxication. A long-term follow-up study. Ital J Neurol Sci (1999) 0.91
The genetics of ataxia: through the labyrinth of the Minotaur, looking for Ariadne's thread. J Neurol (2014) 0.91
A case of music imperception. J Neurol Neurosurg Psychiatry (1993) 0.90
Spontaneous and induced aneuploidy in peripheral blood lymphocytes of patients with Alzheimer's disease. Hum Genet (1997) 0.90
The natural history of the external carotid artery after carotid endarterectomy: implications for management. J Vasc Surg (1996) 0.90
Paraneoplastic choreic syndrome during non-Hodgkin's lymphoma. Mov Disord (2000) 0.89
Indications for breast magnetic resonance imaging. Consensus document "Attualità in senologia", Florence 2007. Radiol Med (2008) 0.89
Differences in nigro-striatal impairment in clinical variants of early Parkinson's disease: evidence from a FP-CIT SPECT study. Eur J Neurol (2009) 0.89
Mitochondrial DNA rearrangements in young onset parkinsonism: two case reports. J Neurol Neurosurg Psychiatry (2001) 0.88
CNS and cutaneous involvement in patients with chronic myeloid leukemia treated with imatinib in hematologic complete remission: two case reports. J Clin Oncol (2003) 0.88
A whole-brain analysis in de novo Parkinson disease. AJNR Am J Neuroradiol (2008) 0.88
Environmental factors and Parkinson's disease: a case-control study in the Tuscany region of Italy. Parkinsonism Relat Disord (2004) 0.87
Contrast-enhanced three-dimensional MR angiography of neck vessels: does dephasing effect alter diagnostic accuracy? Eur Radiol (2002) 0.87
Presynaptic nigro-striatal function in a group of Alzheimer's disease patients with parkinsonism: evidence from a dopamine transporter imaging study. J Neural Transm (Vienna) (2004) 0.86
Amantadine in Huntington's disease: open-label video-blinded study. Neurol Sci (2002) 0.86
Gynecomastia in epileptics treated with phenobarbital, phenytoin and fluoresone: two case reports. Ital J Neurol Sci (1983) 0.86
Interleukin-1 and thromboxane release after skeletal muscle ischemia and reperfusion. Ann Vasc Surg (1992) 0.85
Brain perfusion effects of cholinesterase inhibitors in Parkinson's disease with dementia. J Neural Transm (Vienna) (2006) 0.85
Myopathic involvement in two cases of Hallervorden-Spatz disease. Brain Dev (1996) 0.85
Phenobarbital prophylaxis of post traumatic epilepsy. Ital J Neurol Sci (1980) 0.84
Evaluation of the Short Parkinson's Evaluation Scale: a new friendly scale for the evaluation of Parkinson's disease in clinical drug trials. Clin Neuropharmacol (1997) 0.84
Headache, panic disorder and depression: comorbidity or a spectrum? Neuropsychobiology (1995) 0.84
Spinal cavernous angioma producing subarachnoid hemorrhage. Case report. J Neurosurg Sci (1995) 0.84
A crossover, controlled study comparing pergolide with bromocriptine as an adjunct to levodopa for the treatment of Parkinson's disease. Neurology (1995) 0.84
Chromosome and oxidative damage biomarkers in lymphocytes of Parkinson's disease patients. Int J Hyg Environ Health (2001) 0.83
Disappearance of skin lipofuscin storage and marked clinical improvement in adult onset coeliac disease and severe vitamin E deficiency after chronic vitamin E megatherapy. J Submicrosc Cytol Pathol (1996) 0.83
Dopamine transporter imaging study in parkinsonism occurring in fragile X premutation carriers. Neurology (2005) 0.82
Pergolide compared with bromocriptine in Parkinson's disease: a multicenter, crossover, controlled study. Mov Disord (1994) 0.82
Adrenomyeloneurodystrophy with late cerebral involvement and evidence of a multiple autoimmune disorder. J Inherit Metab Dis (1988) 0.82
Smoking habits in multiple system atrophy and progressive supranuclear palsy. European Study Group on Atypical Parkinsonisms. Neurology (2000) 0.81
Proton magnetic resonance spectroscopy (1H-MRS) of motor cortex and basal ganglia in de novo Parkinson's disease patients. Neurol Sci (2001) 0.81
Plaque surface and microembolic signals in moderate carotid stenosis. Ital J Neurol Sci (1999) 0.81
Possible involvement of dopaminergic mechanisms in the antimigraine action of flunarizine. Cephalalgia (1990) 0.81
Prevalence of headache syndromes in panic disorder. Int Clin Psychopharmacol (1999) 0.81
Neuroendocrine evaluation in catamenial epilepsy. Funct Neurol (1987) 0.81
Observational study of sleep-related disorders in Italian patients with Parkinson's disease: usefulness of the Italian version of Parkinson's disease sleep scale. Neurol Sci (2011) 0.81
Spontaneous regression of intracranial arteriovenous malformation. Surg Neurol (1993) 0.81
Preliminary results of a nonoperative approach to saphenofemoral junction thrombophlebitis. J Vasc Surg (1995) 0.81
Low frequency stimulation of the nucleus tegmenti pedunculopontini increases cortical metabolism in parkinsonian patients. Eur J Neurol (2010) 0.80
The relation between EMG activity and kinematic parameters strongly supports a role of the action tremor in parkinsonian bradykinesia. Mov Disord (2001) 0.80
Superselective intraarterial fibrinolysis in central retinal artery occlusion. AJNR Am J Neuroradiol (1999) 0.80
Epidemiology of progressive supranuclear palsy. ESGAP Consortium. European Study Group on Atypical Parkinsonisms. Neurol Sci (2001) 0.80
IgE serum levels in psoriasis. Dermatologica (1981) 0.80
Prevalence of Parkinson's disease and other types of parkinsonism in the Aeolian Archipelago, Sicily. Parkinsonism Relat Disord (2008) 0.80
Chromatic pattern-reversal electroretinograms (ChPERGs) are spared in multiple system atrophy compared with Parkinson's disease. Neurol Sci (2006) 0.80
Characteristics of cerebral microembolism during carotid stenting and angioplasty alone. Arch Neurol (2001) 0.80
Motor unit number estimation (mune) as a quantitative measure of disease progression and motor unit reorganization in amyotrophic lateral sclerosis. Int J Neurosci (2007) 0.80
Analysis of aneusomy level and HER-2 gene copy number and their effect on amplification rate in breast cancer specimens read as 2+ in immunohistochemical analysis. Eur J Cancer (2006) 0.79
Cytogenetic alterations in lymphocytes of Alzheimer's disease and Parkinson's disease patients. Neurol Sci (2002) 0.79
Pharmacokinetics and pharmacodynamics of L-Dopa after acute and 6-week tolcapone administration in patients with Parkinson's disease. Clin Neuropharmacol (1999) 0.79
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in mice is enhanced by ethanol or acetaldehyde. Life Sci (1987) 0.79
Different effects of levodopa and apomorphine on blink reflex recovery cycle in essential blepharospasm. Eur Neurol (1997) 0.79
Species differences in the role of excitatory amino acids in experimental parkinsonism. Neurosci Biobehav Rev (1997) 0.79
Do cytokines play a role in skeletal muscle ischemia and reperfusion? J Cardiovasc Surg (Torino) (1992) 0.79
Effects of carbamazepine on prolactin secretion in normal subjects and in epileptic subjects. Clin Neuropharmacol (1985) 0.79
Association of intra-abdominal pathologies and vascular anomalies with infrarenal aortic aneurysm: a computed tomographic study. Cardiovasc Surg (1993) 0.79
Spontaneous and induced chromosome damage in somatic cells of sporadic and familial Alzheimer's disease patients. Mutagenesis (2001) 0.79
Oxidative stress and APO E polymorphisms in Alzheimer's disease and in mild cognitive impairment. Free Radic Res (2013) 0.79